Funding for this research was provided by:
Novo Nordisk (NNF20SA0062931)
Received: 6 April 2021
Accepted: 12 July 2021
First Online: 3 August 2021
: This study was approved by the Regional Committees on Health Research Ethics for Southern Denmark ID S-20200047C. Both patients gave informed written consent to participate in the study.
: Both patients gave written informed consent for the publication of these results.
: On behalf of all authors, the corresponding author states that there are no competing interests.